The Cannigma

MARCH 7, 2022

So much attention is placed upon THC and CBD that sometimes the less abundant cannabinoids are forgotten about or not appreciated fully. Yet cannabinol (CBN), the first cannabinoid ever discovered by modern scientists, is slowly making a comeback in the cannabis industry. . What can the current clinical trials tell us?

THC 140

THC Sleep Clinical Trials Cannabinoids 140

Cannabis Law Report

FEBRUARY 2, 2022

The double-blind, randomised, placebo-controlled clinical trial took place over two years between 2017 and 2019 at the Center for Medicinal Cannabis Research at the University of California. medical cannabis users at risk of unfair prosecution, according to a report by Volteface.

Medicine 52

Medicine Clinical Trials Consumption Sleep 52

Cannabis Law Report

JULY 4, 2019

The manuscript is part of EMMAC’s collaboration with Imperial College London, forged to deliver a long-term comprehensive research programme designed to inform and shape the future of the medical cannabis therapeutic industry.

Cannabinoids 40

Cannabinoids Clinical Trials Chronic Pain Medicine 40

The Cannigma

FEBRUARY 2, 2021

“[Parkinson’s disease (PD)] patients fulfilling these criteria are entitled to be prescribed medical cannabis, but there are few data about which type of cannabinoid and which route of administration might be promising for which PD patient, and which symptoms. In 2019, Parkinson’s UK announced the launch of a major £1.2

Patients 87

Patients Clinical Trials Research and Development Treatment 87

Project CBD

AUGUST 6, 2019

The 29th annual International Cannabinoid Research Society ( ICRS ) symposium, which convened last month in Bethesda, Maryland, featured new developments in CBD science that have far-reaching implications for many areas of medicine. None of the participants had been using any cannabinoid-based products prior to this study.

CBD 218

CBD Blood Pressure Research and Development Cannabinoids 218

Project CBD

AUGUST 6, 2019

The 29th annual International Cannabinoid Research Society ( ICRS ) symposium, which convened last month in Bethesda, Maryland, featured new developments in CBD science that have far-reaching implications for many areas of medicine. None of the participants had been using any cannabinoid-based products prior to this study.

CBD 177

CBD Blood Pressure Research and Development Cannabinoids 177

PrestoDoctor

SEPTEMBER 15, 2023

By interacting with the ECS, cannabinoids found in cannabis, such as THC (tetrahydrocannabinol) and CBD (cannabidiol), have the potential to modulate the functioning of this system and alleviate symptoms associated with OCD. Cannabis contains cannabinoids, such as tetrahydrocannabinol (THC) and cannabidiol (CBD), which interact with the ECS.

Research and Development 105

Research and Development Therapy Treatment Strains 105

Cannabis Law Report

MARCH 21, 2019

With so much random information being thrown around the internet, it can be very difficult to differentiate what is true and what is false. All cannabis plants contain cannabinoids, which are a group of similar compounds. If you wish to re-publish this story please do so with following accreditation. AUTHOR: Felipe Rivera.

State Laws 55

State Laws Law CBD Legalization 55

Cannabis Law Report

JANUARY 4, 2022

(Nasdaq: ANEB), a clinical-stage biopharmaceutical company developing novel solutions for people suffering from acute cannabinoid intoxication and substance abuse, has named Simon Allen as Chief Executive Officer and a member of the company’s Board of Directors, effective February 1 st , 2022. Anebulo Pharmaceuticals, Inc.

Pharmaceutical 52

Pharmaceutical Research and Development Clinical Trials Cannabinoids 52

Puff Puff Post

SEPTEMBER 16, 2019

16, 2019 /CNW/ – Québec doctors have a new tool at their disposal for learning about medical cannabis and its viability as a treatment option for their patients. Clinical toolkits to help navigate patient assessment and follow-ups. Event details below: Date: Tuesday, September 17th 2019. Time: 9:00AM to 5:00PM.

Programs 108

Programs Research and Development Education Treatment 108

TheAnswerPage

JANUARY 11, 2022

In fact, from pediatricians to geriatricians, I cannot think of any medical practitioner that does not need to be well informed about the endocannabinoid system and cannabis-based therapeutics. and ‘The Perioperative Considerations for the Patient Utilizing Cannabinoid-based Medicines and Products.’

Patients 98

Patients Education Marijuana Therapy 98

Puff Puff Post

NOVEMBER 5, 2019

5, 2019 /CNW/ – InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (TSX: IN; OTCQX: IMLFF), today announced the filing of a Clinical Trial Application (“CTA”) in the Netherlands to initiate a Phase 1 human clinical trial for INM-755 in healthy volunteers. Adams, CEO.

Clinical Trials 8

Clinical Trials Pharmaceutical Cannabinoids Data 8

The Cannigma

JULY 20, 2021

With this method, you’ll be looking at the most dominant cannabinoids and terpenes in a given cannabis plant, and will choose your cannabis based on their known properties. There are many studies that can speak to these effects, but most of them are pre-clinical, which means they don’t involve human participants. Helping anxiety.

Strains 145

Strains Terpenes Concentrates THC 145

The Cannigma

JANUARY 13, 2023

The authors noted that while “promising data are emerging on the possible role of ECS in migraine…proper placebo-controlled trials are needed to establish a therapeutic role for cannabinoids.” A 2019 retrospective review of 316 patients found that medical cannabis improved the experience of 88.3% headaches per month.

Terpenes 132

Terpenes Strains THC Treatment 132

Cannabis Law Report

MAY 29, 2022

In May 2019, Denver became the first city to decriminalize psilocybin, followed by Oakland, CA, Washington, D.C., In 2019, FDA approved Spravato (esketamine) nasal spray for treatment of depression in adults. [8] Clinical Trials and Human Subject Protections. 5, 2019), [link]. [9] Recent Regulatory Developments.

Research and Development 52

Research and Development DEA Clinical Trials Therapy 52

Cannabis Law Report

NOVEMBER 16, 2019

On 14 November 2019, the Senate referred an inquiry into the current barriers to patient access to medicinal cannabis in Australia to the Senate Community Affairs References Committee for inquiry and report by 12 February 2020. If your submission is published, the information in it, including your name can be searched for on the internet.

Clinical Trials 58

Clinical Trials Access Medicine Patients 58

The Cannigma

JULY 1, 2022

There’s no doubt that the amount of information that is available about cannabis is at an all-time high – in 2020 alone, over 3,500 scientific articles were published on the topic. Different types of research studies provide us with different types of information. What makes a good research study, anyway? Types of Research.

Research and Development 108

Research and Development Data THC Clinical Trials 108

Healer

DECEMBER 17, 2021

Drug interactions reported in the scientific literature most often occur at very high doses used in clinical trials of epilepsy and other conditions. Since cannabinoids, including CBD, share metabolic pathways with other drugs, and have similar mechanisms of action with other drugs, the potential for interaction exists.

CBD 98

CBD THC Conditions Medicine 98

Cannabis Law Report

NOVEMBER 24, 2019

NICE guideline [NG144] Published date: November 2019. Finding more information and committee details. People have the right to be involved in discussions and make informed decisions about their care, as described in your care. Do not offer CBD to manage chronic pain in adults unless as part of a clinical trial.

Medicine 59

Medicine Chronic Pain Research and Development Treatment 59

Cannabis Law Report

SEPTEMBER 24, 2019

September 23, 2019. Cannabidiol oral solution contains highly purified, plant-derived cannabidiol (CBD), a cannabinoid lacking the “high” associated with cannabis. GW’s development programme represents the only well-controlled clinical evaluation of a cannabinoid medication for patients with LGS and Dravet syndrome.

Pharmaceutical 55

Pharmaceutical Epilepsy Research and Development Medicine 55

Cannabis Law Report

MAY 13, 2019

Medical professionals want more information about medicinal cannabis before they start prescribing it to patients, a new study has found. Published: May 6, 2019. Received: December 17, 2018; Accepted: April 23, 2019; Published: May 6, 2019. Copyright: © 2019 Gardiner et al. Gardiner , Judith A.

Medicine 45

Medicine Research and Development Clinical Trials Data 45

Cannabis Law Report

JULY 4, 2021

Cannabidiol or CBD is one of the most common cannabinoids found in cannabis. Clinical trials across the EU have also shown CBD oils and other hemp products to have a potential range of benefits. There are two different types of cannabinoid receptors in your body. What Is CBD? Final Note.

THC 105

THC CBD Legalization Oil 105

Puff Puff Post

SEPTEMBER 16, 2019

16, 2019 /CNW/ – Québec doctors have a new tool at their disposal for learning about medical cannabis and its viability as a treatment option for their patients. Clinical toolkits to help navigate patient assessment and follow-ups. Event details below: Date: Tuesday, September 17th 2019. Time: 9:00AM to 5:00PM.

Programs 40

Programs Research and Development Education Treatment 40

Cannabis Law Report

JUNE 4, 2021

We support the Hemp Roundtable’s statements on psychoactive hemp and that it should be regulated separately from hemp, CBD, CBG and other non-psychoactive or non-intoxicating cannabinoids. Delta 8-THC is a psychoactive cannabinoid, just like Delta 9-THC, and legislators should regulate it as such.

Research and Development 105

Research and Development Seed-To-Sale Cannabinoids THC 105

Cannabis Law Report

JANUARY 9, 2019

Tindall also hope to commence the clinical trials with Vanuatu for diabetes treatment. The firm is expected to engage in M&A activity throughout 2019, and Tindall confirms he is looking at other companies to acquire that will allow Phoenix to leapfrog. Martin Tindall, CEO of Phoenix Life Sciences International.

Therapy 85

Therapy Clinical Trials Treatment Medicine 85

Cannabis Law Report

SEPTEMBER 3, 2019

Awarded Australian Cannabis Industry 2019 Innovation Award. 03, 2019 (GLOBE NEWSWIRE) — MediPharm Labs Corp. Construction of MediPharm Labs Australia’s extraction and manufacturing facility in Wonthaggi, Victoria is progressing very well with completion on target before year-end 2019. For further information, please contact: .

Pharmaceutical 45

Pharmaceutical Extraction Research and Development Supply Chain 45

The Cannigma

JUNE 15, 2021

Cannabidiol (CBD) belongs to a class of molecules called cannabinoids , which are produced almost exclusively in cannabis — hence the name. The two cannabinoids can also cause very different effects in other ways. CBD is also often compared to CBG (cannabigerol) , another increasingly popular cannabinoid. CBD vs CBDA.

CBD 122

CBD Research and Development Epilepsy Extraction 122

CannaMD

MARCH 8, 2020

Few randomized clinical trials have been conducted or are planned to explore the effects of marijuana on cardiovascular risk. Screening and testing for use of marijuana are encouraged in clinical settings, especially in the care of young patients presenting with cardiovascular disease. . More research is needed.

Patients 79

Patients Marijuana Research and Development Clinical Trials 79

Cannabis Law Report

OCTOBER 15, 2021

Xebra’s strategy is to be the absolute first mover in cannabis in Mexico , in advance of formal legalization, by obtaining a Supreme Court injunction to legally commercialize hemp derived cannabinoids such as CBD and CBG. All statements, other than statements of historical facts, are forward-looking information and statements.

Seed-To-Sale 52

Seed-To-Sale Cultivation Clinical Trials Cannabinoids 52

The Cannigma

AUGUST 26, 2021

A major move in the direction of legalization took place in September 2019, when the Australian Capital Territory legalized cannabis possession (up to 50 grams) and the cultivation of up to two cannabis plants. Doctors must receive the patient’s informed consent before they can apply to the TGA to access an unapproved product.

Legalization 52

Legalization Access Medicine Clinical Trials 52

Cannabis Law Report

NOVEMBER 7, 2019

As of August 2019, authorities in Australia have granted approximately 14,500 approvals, under the Special Access Scheme, for the legal use of medicinal cannabis. With a strong focus on research and development ranging from agronomic research through to clinical trials Cannatrek has an extensive R&D portfolio from Seed to Patient.

Medicine 40

Medicine Patients Research and Development Clinical Trials 40

Healer

DECEMBER 17, 2021

Drug interactions reported in the scientific literature most often occur at very high doses used in clinical trials of epilepsy and other conditions.[1]. Since cannabinoids, including CBD, share metabolic pathways with other drugs, and have similar mechanisms of action with other drugs, the potential for interaction exists.

CBD 52

CBD THC Conditions Medicine 52

Cannabis Law Report

JANUARY 18, 2019

14, 2019 /PRNewswire/ — The world’s top cannabis industry leaders will convene in an unprecedented gathering in Davos, Switzerland from January 22-25. Several of these products have already completed or been approved for clinical trials in Israel. More information about TheraCann is available at [link].

Research and Development 40

Research and Development Clinical Trials Extraction Therapy 40

Cannabis Law Report

NOVEMBER 24, 2021

Using a content analysis approach, we investigated articles about medicinal cannabis from 2000 to the end of 2019 in the Medical Journal of Australia, Australian Doctor , Medical Observer , Australian Journal of General Practice , Australian Family Physicia n , and Australian Medicine. 2016 ; Sznitman et al. 2016 ; Sznitman et al.

Research and Development 52

Research and Development Medicine Access Media 52

Cannabis Law Report

JULY 23, 2019

After using Koi’s products, Thurston was given a random drug test by her employer, which came back positive for cannabinoids. Therefore, on 31 December 2018 the commission sent a legislative report to Maryland’s General Assembly that laid the groundwork for several bills submitted during the 2019 legislative session.

Law 40

Law Clinical Trials CBD Edibles 40

Puff Puff Post

DECEMBER 28, 2018

An official study is aimed to conclude in July of 2019, where we’ll see all the data which comes forth. Influencing how information is processed and how nerve cells and synapses in the brain interact, the exact function related to autism is still not well understood, and no pharmaceuticals around yet can ‘fix’ autism.

Treatment 76

Treatment Oil CBD Therapy 76

Cannabis Law Report

JANUARY 11, 2019

Furthermore, by redefining hemp to include its “extracts, cannabinoids and derivatives,” Congress explicitly removed popular hemp products – such as hemp-derived CBD — from the purview of the CSA. It is now deemed an agricultural commodity, no longer able to be classified as a controlled substance, like marijuana.

Hemp 49

Hemp CBD Law Seed-To-Sale 49